Literature DB >> 16986934

Total synthesis and comparative analysis of orlistat, valilactone, and a transposed orlistat derivative: Inhibitors of fatty acid synthase.

Gil Ma1, Manuel Zancanella, Yatsandra Oyola, Robyn D Richardson, Jeffrey W Smith, Daniel Romo.   

Abstract

Concise syntheses of orlistat (Xenical), a two-carbon transposed orlistat derivative, and valilactone are described that employ the tandem Mukaiyama aldol-lactonization (TMAL) process as a key step. This process allows facile modification of the alpha-side chain. Versatile strategies for modifying the delta-side chain are described, involving cuprate addition and olefin metathesis. Comparative antagonistic activity of these derivatives toward a recombinant form of the thioesterase domain of fatty acid synthase is reported along with comparative activity-based profiling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16986934     DOI: 10.1021/ol061651o

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  11 in total

1.  A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids.

Authors:  Mingzhao Zhu; Wayne D Harshbarger; Omar Robles; Joanna Krysiak; Kenneth G Hull; Sung Wook Cho; Robyn D Richardson; Yanyan Yang; Andres Garcia; Lindsey Spiegelman; Bianca Ramirez; Christopher T Wilson; Ju Anne Yau; James T Moore; Caitlen B Walker; James C Sacchettini; Wenshe R Liu; Stephan A Sieber; Jeffrey W Smith; Daniel Romo
Journal:  Bioorg Med Chem       Date:  2017-01-19       Impact factor: 3.641

2.  Catalytic Asymmetric Synthesis of Ketene Heterodimer β-Lactones: Scope and Limitations.

Authors:  Shi Chen; Ahmad A Ibrahim; Nicholas J Peraino; Divya Nalla; Mukulesh Mondal; Maxwell Van Raaphorst; Nessan J Kerrigan
Journal:  J Org Chem       Date:  2016-08-12       Impact factor: 4.354

Review 3.  Metabolic alterations and targeted therapies in prostate cancer.

Authors:  Richard Flavin; Giorgia Zadra; Massimo Loda
Journal:  J Pathol       Date:  2010-11-16       Impact factor: 7.996

Review 4.  Fatty acid synthase as a potential therapeutic target in cancer.

Authors:  Richard Flavin; Stephane Peluso; Paul L Nguyen; Massimo Loda
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

5.  Stereochemical Structure Activity Relationship Studies (S-SAR) of Tetrahydrolipstatin.

Authors:  Xiaofan Liu; Yanping Wang; Richard I Duclos; George A O'Doherty
Journal:  ACS Med Chem Lett       Date:  2018-02-21       Impact factor: 4.345

6.  Diastereoselective synthesis of tetrahydrofurans via mead reductive cyclization of keto-beta-lactones derived from the tandem Mukaiyama aldol lactonization (TMAL) process.

Authors:  T Andrew Mitchell; Daniel Romo
Journal:  J Org Chem       Date:  2007-11-01       Impact factor: 4.354

7.  Synthesis of novel beta-lactone inhibitors of fatty acid synthase.

Authors:  Robyn D Richardson; Gil Ma; Yatsandra Oyola; Manuel Zancanella; Lynn M Knowles; Piotr Cieplak; Daniel Romo; Jeffrey W Smith
Journal:  J Med Chem       Date:  2008-08-19       Impact factor: 7.446

8.  Catalyst free N-formylation of aromatic and aliphatic amines exploiting reductive formylation of CO2 using NaBH4.

Authors:  Arun Kumar; Pankaj Sharma; Nidhi Sharma; Yashwant Kumar; Dinesh Mahajan
Journal:  RSC Adv       Date:  2021-07-27       Impact factor: 4.036

9.  MoS2-Catalyzed transamidation reaction.

Authors:  Feng Zhang; Lesong Li; Juan Ma; Hang Gong
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

10.  Total synthesis of tetrahydrolipstatin and stereoisomers via a highly regio- and diastereoselective carbonylation of epoxyhomoallylic alcohols.

Authors:  Michael Mulzer; Brandon J Tiegs; Yanping Wang; Geoffrey W Coates; George A O'Doherty
Journal:  J Am Chem Soc       Date:  2014-07-18       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.